Analysis of 20,000 participants raises doubts about the effectiveness of Alzheimer’s medication

Date:

Share this article:

Del denne artikel:

New research examines the effects of newer drugs for Alzheimer’s disease.

In recent years, medications have been developed that aim to influence Alzheimer’s in the brain.

A large review published in the Cochrane Database of Systematic Reviews, which compiles results from multiple studies, has taken a closer look at these effects.

The analysis is based on 17 studies involving around 20,000 participants. Patients were treated for 18 months and compared with a group receiving a placebo.

The results show that the medication only slows problems with memory, thinking, and daily activities to a very limited extent.

Also read: How to avoid excess liquid when frying mushrooms

Side effects such as brain swelling and small hemorrhages were also identified.

Criticism of methodology

However, several researchers believe the analysis has weaknesses.

According to a commentary in The Lancet, it is problematic that studies of different types of medication have been combined.

Some of the older drugs showed no effect, while newer treatments in certain studies have demonstrated better results. This may therefore present a misleading picture.

Also read: This happens in your body if you eat more protein than carbs

At the same time, diagnostic methods have improved over time.

This means that some earlier studies may have included patients who did not have Alzheimer’s disease.

Major considerations

Health authorities are still assessing whether the new treatments should be introduced. This requires significant resources and close monitoring of patients.

Researchers also point out the need to investigate other ways of treating the disease.

Also read: Pepsi Max may be linked to faster cognitive decline

Sources: Forskning.no, Cochrane Database of Systematic Reviews, and The Lancet.

Also read: Research: Timing of your meals may affect your weight

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

Taking Ozempic or Wegovy? The FDA just added a vision-loss warning to the label

Behind the label change is a single eye condition and a rate that quietly doubled compared with the trials' control groups.

Five breathing techniques that may calm anxiety in just a few minutes

All five patterns have research behind them, but one stood out for how fast it works.

How eating tomatoes every day may affect your heart and cancer risk

A cheap kitchen staple keeps showing up in major heart and cancer reviews, and the daily amount is smaller than you'd expect.

What your gums can reveal about your heart health and disease risk

What a dentist spots at your next checkup may say something about the blood vessels around your heart, not just about your teeth.

Taking Ozempic or Wegovy? The FDA just added a vision-loss warning to the label

Behind the label change is a single eye condition and a rate that quietly doubled compared with the trials' control groups.

Five breathing techniques that may calm anxiety in just a few minutes

All five patterns have research behind them, but one stood out for how fast it works.

How eating tomatoes every day may affect your heart and cancer risk

A cheap kitchen staple keeps showing up in major heart and cancer reviews, and the daily amount is smaller than you'd expect.